We are live on ! Find out more
PCRX icon

Pacira BioSciences
PCRX

260 hedge funds and large institutions have $3.01B invested in Pacira BioSciences in 2020 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 105 increasing their positions, 84 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 23

25% more repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 84

13% more call options, than puts

Call options by funds: $10.1M | Put options by funds: $8.96M

3.01% more ownership

Funds ownership: 112.93% → 115.94% (+3%)

1% more funds holding

Funds holding: 257 → 260 (+3)

4% more capital invested

Capital invested by funds: $2.9B → $3.01B (+$115M)

40% less funds holding in top 10

Funds holding in top 10: 5 → 3 (-2)

Holders
260
Holders Change
+3
Holders Change %
+1.17%
% of All Funds
4.6%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.05%
New
29
Increased
105
Reduced
84
Closed
23
Calls
$10.1M
Puts
$8.96M
Net Calls
+$1.18M
Net Calls Change
+$5.36M

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$34.2M
2
BlackRock
BlackRock
New York
+$25.7M
3
Macquarie Group
Macquarie Group
Australia
+$18M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$17.1M
5
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
+$13.6M

Top Sellers

Rank Fund Capital Flow
1
LCG
Lisanti Capital Growth
New York
-$10.1M
2
Renaissance Technologies
Renaissance Technologies
New York
-$9.08M
3
DM
Deerfield Management
New York
-$8.68M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$8.11M
5
DCM
Driehaus Capital Management
Illinois
-$7.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
COPPSERS
101
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$2.01M +$28.5K +487 +1%
VOYA Investment Management
102
VOYA Investment Management
Georgia
$1.9M +$420K +7,168 +29%
Two Sigma Advisers
103
Two Sigma Advisers
New York
$1.6M +$123K +2,100 +9%
Skandinaviska Enskilda Banken (SEB)
104
Skandinaviska Enskilda Banken (SEB)
Sweden
$1.58M – – –
Manulife (Manufacturers Life Insurance)
105
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.52M +$62.3K +1,064 +4%
Ensign Peak Advisors
106
Ensign Peak Advisors
Utah
$1.51M +$322K +5,500 +28%
DA
107
Duality Advisers
Florida
$1.51M +$1.48M +25,251 New
OF
108
Outfitter Financial
Maine
$1.51M +$1.48M +25,240 New
Los Angeles Capital Management
109
Los Angeles Capital Management
California
$1.44M +$16.1K +275 +1%
DekaBank Deutsche Girozentrale
110
DekaBank Deutsche Girozentrale
Germany
$1.43M -$714K -12,200 -33%
Susquehanna International Group
111
Susquehanna International Group
Pennsylvania
$1.37M -$1.47M -25,115 -52%
Royal Bank of Canada
112
Royal Bank of Canada
Ontario, Canada
$1.34M +$897K +15,320 +216%
GIM
113
Goelzer Investment Management
Indiana
$1.33M -$6.5K -111 -0.5%
PCM
114
Princeton Capital Management
New Jersey
$1.32M +$29.3K +500 +2%
Neuberger Berman Group
115
Neuberger Berman Group
New York
$1.24M +$212K +3,613 +21%
HSBC Holdings
116
HSBC Holdings
United Kingdom
$1.2M +$211K +3,598 +22%
LSERS
117
Louisiana State Employees Retirement System
Louisiana
$1.2M +$11.7K +200 +1%
JG
118
Jefferies Group
New York
$1.17M +$384K +6,550 +50%
MIM
119
MetLife Investment Management
New Jersey
$1.11M – – –
KBC Group
120
KBC Group
Belgium
$1.06M – – –
TFA
121
Toth Financial Advisory
Virginia
$1.05M +$167K +2,855 +19%
Fisher Asset Management
122
Fisher Asset Management
Washington
$1.05M +$114K +1,948 +13%
American Century Companies
123
American Century Companies
Missouri
$1.04M -$298K -5,097 -23%
OPERF
124
Oregon Public Employees Retirement Fund
Oregon
$1.03M -$3.46K -59 -0.3%
ProShare Advisors
125
ProShare Advisors
Maryland
$1.02M +$245K +4,185 +33%
3 4
5
6 7

PCRX Hedge Fund Activity: Q4 2020 in Review

260 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q4 2020, worth a combined $3.01B — up 4% from $2.9B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new PCRX positions and 23 closed out — a net gain of 6 holders — while 105 added to existing stakes and 84 trimmed.

The largest buyer was Wells Fargo, adding an estimated $34.2M. The largest seller was Lisanti Capital Growth, exiting entirely with an estimated $10.1M sold.

  • 260 institutional investors held Pacira BioSciences (PCRX) as of Q4 2020, up from 257 in Q3 2020.
  • Funds reported $3.01B of Pacira BioSciences stock for Q4 2020, up 4% quarter-over-quarter.
  • 29 funds opened new Pacira BioSciences positions in Q4 2020 and 23 closed out, a net change of +6 holders.
  • The largest Pacira BioSciences buyer in Q4 2020 was Wells Fargo, an estimated $34.2M added.
  • The largest Pacira BioSciences seller in Q4 2020 was Lisanti Capital Growth, an estimated $10.1M sold.

Based on aggregated 13F filings for Q4 2020.